CPIX - Cumberland Pharmaceuticals Inc
Cumberland Pharmaceuticals Inc Logo

CPIX - Cumberland Pharmaceuticals Inc

https://www.cumberlandpharma.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and marketing of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company is headquartered in Nashville, Tennessee.

52W High
$7.25
52W Low
$1.04
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
-0.37
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
12.53
EV/Revenue (<3 favorable)
1.04
P/S (TTM) (<3 favorable)
1.18
P/B (<3 favorable)
1.77
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
41.57%
Institutions (25–75% balanced)
24.77%
Shares Outstanding
14,959,900
Float
7,969,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
42,071,800
Gross Profit (TTM)
35,335,200
EPS (TTM)
-0.22
Profit Margin (>10% good)
-0.07%
Operating Margin (TTM) (higher better)
-0.07%
ROE (TTM) (>15% strong)
-0.11%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.10
Momentum
Bearish momentum
Value
0.0200
Previous
0.0190
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025